Trial Information

Do you have Type 1 Diabetes? Rainier Clinical Research Center is seeking participants who have been diagnosed with type 1 diabetes and are interested in participating in a study of a new investigational insulin

Participants are needed for a research study of an investigational insulin to see if it helps to improve blood sugar levels.

Qualified participants will receive at no cost: insulin, study-related physical exams, EKG, glucose meter, supplies, and financial compensation for time and travel. This study is conducted by doctors who specialize in diabetes.

Patient Inclusion Criteria:

Must be 18 years old or older
HbA1c < 12%
Been diagnosed with Type 1 diabetes for at least the past year.
Must be treated for at least 90 days prior to enrollment with:
- insulin detemir, insulin glargine, or NPH insulin in combination with premeal insulin.
- self-mixed or pre-mixed insulin regimens with any basal and bolus insulin combinatior administered at least twice daily
- continuous subcutaneous insulin infusion therapy

Patient Exclusion Criteria:

Receive any oral or injectable medication (other than Metformin for treatment of polycystic ovarian disease) intended for the treatment of diabetes other than insulin in the past 90 days.
Had more than 1 episode of severe hypoglycemia in the past 6 months or 2 or more hospitalizations due to poor diabetes control in the past 6 months.

Jeff Klaff or John McKenney
Rainier Clinical Research Center, Inc.
723 SW 10th St.
Suite 100
Renton, WA 98057
Phone: 1-888-478-8343
Email: rcrc@rainier-research.com

View Map

Research Center Information: Rainier Clinical Research Center, Inc.

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:
Message:

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.